Cargando…
BRCA1 mediates protein homeostasis through the ubiquitination of PERK and IRE1
Tumors with BRCA1 mutations have poor prognoses due to genomic instability. Yet this genomic instability has risks and BRCA1-deficient (def) cancer cells must develop pathways to mitigate these risks. One such risk is the accumulation of unfolded proteins in BRCA1-def cancers from increased mutation...
Autores principales: | Hromas, Robert, Srinivasan, Gayathri, Yang, Ming, Jaiswal, Aruna, Totterdale, Taylor A., Phillips, Linda, Kirby, Austin, Khodayari, Nazli, Brantley, Mark, Williamson, Elizabeth A., Kong, Kimi Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719099/ https://www.ncbi.nlm.nih.gov/pubmed/36471805 http://dx.doi.org/10.1016/j.isci.2022.105626 |
Ejemplares similares
-
The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells
por: Hromas, Robert, et al.
Publicado: (2017) -
MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers
por: Srinivasan, Gayathri, et al.
Publicado: (2019) -
Divergent Effects of PERK and IRE1 Signaling on Cell Viability
por: Lin, Jonathan H., et al.
Publicado: (2009) -
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
por: Srinivasan, Gayathri, et al.
Publicado: (2017) -
A humanized monoclonal antibody against the endothelial chemokine CCL21 for the diagnosis and treatment of inflammatory bowel disease
por: Capitano, Maegan L., et al.
Publicado: (2021)